Skip to content
Back to Guavy Wire
Stocks

DeepMind Releases Massive Genome Dataset to Speed Up Rare Disease Research

Instruments
GOOGL
Share

DeepMind has released a massive dataset of precomputed predictions for every possible single-letter change in the human genome, called AlphaGenome Atlas. This dataset is a petabyte in size and contains predictions for all 9 billion possible changes.

The predictions are based on a combination of two models: AlphaGenome and AlphaMissense. Each variant gets an AlphaGenome Variant Impact score, which combines the results of both models.

The dataset was validated using whole genomes from over 54,000 UK Biobank participants at Exeter, where researchers found 22% more non-coding associations. The Broad Institute also used the score to surface a variant in the DNM1 gene that creates an incorrect splice site, which was confirmed by experimental screens.

The AlphaGenome Atlas is currently free for academic use, but commercial access will soon be available on Google Cloud, where DeepMind has already sold specialist science models. This raises questions about how European law will treat the two tracks: scientific research and development versus commercial use.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc